Efficacy of a spring strategic treatment program with fenbendazole (FBZ) to reduce the accumulation of Ostertagia ostertagi inhibited early fourth-stage larvae (EL4) was investigated in two groups of crossbred beef heifers which were 7-9 months of age and ranged in weight from 155 to 223 kg. The cattle were allocated to groups and treated on 27 April (Day 0). Group 1 calves served as nontreated controls. Group 2 calves were treated with FBZ 10% drench suspension at 5 mg kg-1 on Day 0 and with 6-day courses of FBZ free-choice mineral (to provide 5 mg kg-1 per animal) on Days 28 and 56. Each group grazed on a separate 4.9 ha pasture for 105 days to 10 August. On 10 August the cattle were taken off pasture and each original group was re-allocated to subgroups of three cattle which were treated orally with FBZ (5 mg kg-1), oxfenbendazole (OXF, 4.5 mg kg-1) or left nontreated (CONT). The cattle were necropsied on Days 120 and 121. Mean actual and cumulative fecal egg counts indicated near total suppression of egg output in the strategically treated group (high of 5.2 eggs g-1 feces (EPG) on Day 28). Egg counts of the nontreated group remained above 100 or 200 EPG to Day 63 and then decreased to less than 100. Ostertagia was the predominant genus, followed by Cooperia on most sampling dates. The largest O. ostertagi worm burdens were recovered from the CONT-CONT subgroup; numbers of EL4 ranged from 18,922 to 51,137. Reduction in numbers of EL4 in original controls, treated with FBZ or OXF in August, were low, being 60.2% and 74.3%, respectively. The numbers of O. ostertagi recovered from subgroups originally treated strategically with FBZ were generally lower than in original controls. The largest reduction in O. ostertagi numbers was in the FBZ-CONT subgroup, which was not treated in August. Percent reduction values for O. ostertagi adults, developing L4 (DL4) and EL4 were 84.6%, 96.7%, and 99.0%, respectively. Percent reduction values for adults, DL4 and EL4 in the FBZ-FBZ and FBZ-OXF subgroups were 90.7%, 61.3%, 85.6% and 92.4%, 45.5%, and 73.0%, respectively. Variability in numbers of EL4 acquired during grazing by original controls and strategically treated cattle and variability in efficacy of August treatments was evident as observed in high outlier numbers of worms in all subgroups except the FBZ-CONT subgroup. Liveweights and gains were nearly identical in the two groups on 10 August.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0304-4017(94)00745-x | DOI Listing |
Placenta
September 2024
Departments of Central Laboratory, Jinhua Municipal Central Hospital, Jinhua, Zhejiang, 321000, PR China. Electronic address:
Introduction: Toxoplasma gondii is an opportunistic intracellular parasite that is a major pathogenic factor in miscarriage, especially when it occurs early in pregnancy. We have previously demonstrated that the regulation of forkhead box transcription factor (Foxp3) is associated with abortion in early pregnancy caused by excretory-secretory antigen (ESA) of strain China 1. We aimed to reveal the underlying mechanism of miscarriage caused by ESA.
View Article and Find Full Text PDFCell Oncol (Dordr)
October 2024
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Purpose: Leukaemia remains a major contributor to global mortality, representing a significant health risk for a substantial number of cancer patients. Despite notable advancements in the field, existing treatments frequently exhibit limited efficacy or recurrence. Here, we explored the potential of abolishing HVEM (herpes virus entry mediator, TNFRSF14) expression in tumours as an effective approach to treat acute lymphoblastic leukaemia (ALL) and prevent its recurrence.
View Article and Find Full Text PDFFront Immunol
April 2024
Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Cutaneous T-cell lymphomas (CTCL) are a group of lymphoproliferative disorders of skin-homing T cells causing chronic inflammation. These disorders cause impairment of the immune environment, which leads to severe infections and/or sepsis due to dysbiosis. In this study, we elucidated the host-microbial interaction in CTCL that occurs during the phototherapeutic treatment regime and determined whether modulation of the skin microbiota could beneficially affect the course of CTCL.
View Article and Find Full Text PDFParasit Vectors
April 2024
Department of Pathogen Biology, School of Medicine, Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, People's Republic of China.
Front Pharmacol
April 2022
Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Myeloid-derived suppressor cells (MDSCs) are major immunosuppressive cells that accumulate in tumor-bearing hosts. Since MDSCs suppress anti-tumor immunity and promote tumor progression, they are promising targets for cancer immunotherapy. Granulocyte colony-stimulating factor (G-CSF) is an agent used for the treatment of chemotherapy-induced febrile neutropenia (FN) in patients with cancer.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!